Skip to content
PodParley
AZense Guideline Updates podcast artwork

PODCAST · health

AZense Guideline Updates

by Azense Medical Education

AZense Guideline Updates is the companion podcast to AZense Journal Club. Each episode distills a major clinical practice guideline into a practical bedside reference for residents, hospitalists, PAs, NPs, and practicing clinicians. AI-generated voices, physician-reviewed scripts from Azense Medical Education, an Azense AI LLC educational project. For clinical education only, not individual medical advice.

Publisher-supplied feed metadata · PodParley refreshed Sep 23, 2026 · Source feed

Subscribe · 0 Bookmark

Episodes

  1. Guideline Updates G49: Midodrine: Pressor Bridge or Chronic Therapy?

    A hospitalist-focused evidence update on long-term versus temporary midodrine use, covering neurogenic orthostatic hypotension, vasovagal syncope, cirrhosis, HRS-AKI, ICU vasopressor liberation, dialysis hypotension, HFrEF, and safety monitoring.

  2. G48 · Pulmonary Hypertension: Diagnose the Group Before Treating the Pressure

    A hospitalist-focused guideline review on PH diagnosis, hemodynamic classification, the five PH groups, treatment by group, complications, and right-ventricular failure safety.

  3. G47 · Interstitial Lung Disease for the Hospitalist: Recognize, Classify, and Avoid the Big Misses

    A practical ILD guideline episode covering HRCT patterns, IPF, progressive pulmonary fibrosis, hypersensitivity pneumonitis, autoimmune ILD, drug toxicity, acute deterioration, steroids, antifibrotics, and referral.

  4. Guideline Updates G46: Oncologic and Hematologic Emergencies for the Hospitalist

    A first-hour playbook for febrile neutropenia, sepsis physiology, tumor lysis, hypercalcemia, spinal cord compression, superior vena cava syndrome, leukostasis, DIC, TTP, hyperviscosity, CAR T-cell and bispecific toxicity, checkpoint emergencies, and urgent consultation.

  5. Guideline Updates G45: Neurosurgical Emergencies for the Hospitalist

    A practical first-hour map for brain bleeds, stroke triage, herniation, hydrocephalus, spinal cord emergencies, tumor edema, seizures, reversal, pressure targets, and transfer calls.

  6. Guideline Updates G44: Testosterone After TRAVERSE: Two Morning Levels, Four New Questions

    Diagnosing hypogonadism properly, reading TRAVERSE and its substudies, and living with the 2025–2026 label changes.

  7. Guideline Updates G43: Valve Referral in 2026: TAVR, TEER, and When Surgery Still Wins

    Aortic stenosis and mitral regurgitation indications across US 2020 and ESC 2025 guidance, with the trials that changed the referral map.

  8. Guideline Updates G42: HFpEF in 2026: The New ACC Pathway, Decoded

    Diagnosis scores, cardiometabolic therapy, decongestion targets, and the line between an expert pathway and a guideline.

  9. Guideline Updates G41: Adrenal Insufficiency: From Sick-Day Rules to Adrenal Crisis

    Morning cortisol, replacement, stress-dose coverage, and the emergency treatment that precedes the labs.

  10. Guideline Updates G40: Hyperthyroidism & Thyrotoxicosis: From Graves to Thyroid Storm

    Cause-first diagnosis, thionamide safety, inpatient traps, and the storm sequence that cannot be reversed.

  11. Guideline Updates G39: Hypothyroidism: From TSH to Myxedema Coma

    Diagnosis, dosing, inpatient logistics, and the endocrine emergency hospitalists cannot miss.

  12. Guideline Updates G38: The Angry Urine: Intrinsic Renal Disease Patterns

    Nephritic vs nephrotic, the RPGN serology decoder, AIN vs ATN, TMA, myeloma cast nephropathy, rhabdo, and crystal nephropathy - the nine intrinsic buckets a hospitalist has to sort at the bedside.

  13. Guideline Updates G37: The First 24 Hours: Cracking Inpatient AKI

    KDIGO staging, the pre/intrinsic/post framework, urine microscopy that actually changes management, and when to call nephrology - a hospitalist's field guide.

  14. Guideline Updates G36: Salt Lines: Cracking Hyponatremia and Hypernatremia on the Wards

    A bedside playbook for IM residents and hospitalists - from the 3 AM critical sodium page to safe discharge. Correct too slowly and the brain swells; correct too fast and you cause osmotic demyelination. Almost every recommendation in this space exists to help you walk that tightrope.

  15. Guideline Updates G35: Shock Guidelines: An Integrated Playbook

    There is no single shock guideline. This episode stitches together the current evidence across the four shock phenotypes - cardiogenic, septic, hemorrhagic, and obstructive - plus a point-of-care ultrasound approach to the undifferentiated hypotensive patient, so you can recognize the phenotype…

    more

  16. Guideline Updates G34: C. diff in 2026: Fidaxomicin First, FMT Reconsidered

    An old-rule versus new-rule walk through two documents: the IDSA/SHEA 2021 antibiotic update that made fidaxomicin preferred and demoted metronidazole, and the AGA 2024 guideline that turned fecal microbiota-based therapy into a structured, risk-stratified recommendation whose answer flips…

    more

  17. Guideline Updates G33: Status Epilepticus: The First 60 Minutes

    A stopwatch walk through the time-critical window. The five-minute operational definition, first-line benzodiazepine dosing and route, second-line ASM choices, refractory SE and mandatory continuous EEG, and the ICS 2025 philosophy of hunting for the cause in parallel with stopping the seizure.

  18. Guideline Updates G32: Antibiotic Stewardship Advanced: Empiric Regimens by Syndrome

    Part two of a two-part stewardship curriculum: syndrome-by-syndrome empiric choices, de-escalation, and usual durations - from CAP and sepsis to endocarditis, bacteremia, and the resistant-organism curveballs, with what actually changed in 2024-2026 (the 2025 CAP steroid reversal, the first-ever...

  19. Guideline Updates G31: Antibiotic Stewardship Basics: Bugs, Drugs, and First-Line Logic

    Part one of a two-part curriculum. How to reason from Gram stain to a narrow, correct regimen: the gram-negative and gram-positive coverage maps, organism-specific first-line logic, the MSSA-off-vancomycin reflex, the resistant-organism villains in plain language, and the four stewardship habits…

    more

  20. Guideline Updates G30: Hospital Management of Decompensated Cirrhosis (Part 2)

    The complications deep dive: hepatic encephalopathy and the ammonia trap, reading the ascitic tap and the SBP prophylaxis controversy, variceal bleeding drug and PPI decisions, HRS-AKI with terlipressin guardrails, why chest tubes harm in hepatic hydrothorax, and using ACLF grade rather than MELD...

  21. Guideline Updates G29: Hospital Management of Decompensated Cirrhosis (Part 1)

    The 2025 BSG/BASL/SAM admission bundle tightens the first 6 hours, adds Doppler ultrasound, and drops routine coagulopathy correction, while AASLD, AGA, EASL, and ACG guidance reshape SBP, HRS-AKI, variceal bleeding, portal vein thrombosis, and alcohol-associated hepatitis

  22. Guideline Updates G28: Protecting the Aorta: The 2022 AHA/ACC Aortic Disease Guideline

    The 2022 ACC/AHA aortic disease guideline unifies thoracic and abdominal aortic care, lowers surgical thresholds at expert centers, expands genetic testing and family screening, and standardizes acute aortic syndrome management

  23. Guideline Updates G27: Beyond Beta-Blockers: The 2023 Chronic Coronary Disease Guideline

    The 2023 AHA/ACC chronic coronary disease guideline renames stable ischemic heart disease, elevates SGLT2 inhibitors and GLP-1 therapies, de-escalates routine long-term beta-blockers, and ties revascularization to symptoms rather than ischemia alone

  24. Guideline Updates G26: Everything Is Connected: The 2026 CKM Syndrome Guideline

    The first unified AHA/ACC/ADA/ASN guideline defines cardiovascular-kidney-metabolic syndrome, introduces a 0 to 4 staging system, mandates PREVENT-based risk estimation, and places SGLT2 inhibitors and GLP-1 therapies at the center of cardiometabolic care

  25. Guideline Updates G25: SIS 2024 Intra-Abdominal Infection Therapy: The Treatment Half of the Belly, and When to Reach for an Antifungal

    The Surgical Infection Society 2024 update is the antimicrobial and antifungal therapy companion to IDSA 2024 Part 1, which covered diagnosis only; it advises against empiric antifungals in lower-risk community-acquired infection and recommends anidulafungin for higher-risk Candida…

    more

  26. Guideline Updates G24: IDSA 2024 Intra-Abdominal Infections, Part 1: Diagnosing the Belly Before You Treat It

    The IDSA 2024 update on complicated intra-abdominal infections, Part 1, covers risk assessment, diagnostic imaging, and microbiological evaluation only; antimicrobial therapy, source control, and antifungal guidance are reserved for later parts

  27. Guideline Updates G23: CHEST 2025 Plasma and Platelet Guideline: Don't Top Them Off, Except for the LP

    The CHEST 2025 companion guideline issues seven conditional recommendations that withhold prophylactic plasma and platelet transfusion in most ICU settings, with lumbar puncture as the one procedure that flips the default

  28. Guideline Updates G22: CHEST 2024 RBC Transfusion Guideline: Restrictive by Default, with One Big Exception

    The CHEST 2024 red cell transfusion guideline makes a restrictive hemoglobin 7 to 8 strategy the strong default across critical illness and GI bleeding, but recommends against a restrictive strategy in acute coronary syndrome

  29. Guideline Updates G21: KDIGO 2024 CKD Guideline: When to Use SGLT2 Inhibitors

    The 2024 KDIGO CKD guideline gives a tiered SGLT2 inhibitor recommendation, strong for type 2 diabetes with CKD, strong for heavy albuminuria or heart failure regardless of diabetes, and a weaker suggestion for low-albuminuria low-eGFR disease, not a blanket recommendation for all CKD

  30. Guideline Updates G20: IDSA 2024 AMR Guidance: Treating ESBL, CRE, CRAB, and DTR-Pseudomonas

    The living IDSA guidance retires piperacillin-tazobactam for serious ESBL disease, makes ceftazidime-avibactam standard for KPC-type CRE, prefers sulbactam-durlobactam for CRAB, and requires novel agents for DTR-Pseudomonas

  31. Guideline Updates G19: Inpatient Hyperglycemia: ADA 2025 Section 16 and the Endocrine Society 2022 Guideline Aligned

    Basal-bolus insulin is the standard for eating non-ICU patients, targets are 140 to 180 mg/dL for most, admission A1C drives the plan, and sliding scale alone is not adequate

  32. Guideline Updates G18: IDSA 2025 Complicated UTI Guideline: New Clinical Definitions and Empiric Therapy

    The 2025 IDSA update defines complicated UTI by clinical findings rather than risk factors alone, retires fluoroquinolones as empiric therapy, and favors carbapenems over piperacillin-tazobactam for ESBL disease

  33. Guideline Updates G17: 2026 AHA/ASA Acute Ischemic Stroke Guideline: Tenecteplase, Dual Antiplatelet, and Large-Core Thrombectomy

    The 2026 update makes tenecteplase co-equal with alteplase, replaces thrombolysis with dual antiplatelet therapy for non-disabling stroke, and expands thrombectomy to large-core infarcts

  34. Guideline Updates G16: Asthma in 2026: GINA Tracks, Exacerbations, and Severe Asthma Referral

    A practical adult asthma guideline review: diagnosis, Track 1 versus Track 2, AIR/MART therapy, acute exacerbation care, discharge safety, and biologic-ready severe asthma workup.

  35. Guideline Updates G15: GLP-1s in 2026: Obesity as Chronic Disease, Outcomes, and Inpatient Safety

    WHO and AACE guidance, semaglutide and tirzepatide landmark trials, complication-targeted prescribing, and what hospitalists must ask when patients present with GI and renal complications.

  36. Guideline Updates G14: ADA Standards of Care 2025: CGM for Non-Insulin Diabetes, MASLD Treatment, and Perioperative GLP-1 Rules

    The 2025 ADA Standards expand continuous glucose monitoring to non-insulin type 2 diabetes, add resmetirom for MASLD with fibrosis, ban DPP-4 plus GLP-1 combinations, and formalize perioperative GLP-1 guidance

  37. Guideline Updates G13: Dyslipidemia 2026: LDL Goals Return, PREVENT-ASCVD Risk, and a Once-in-a-Lifetime Lp(a)

    The 2026 ACC/AHA multisociety guideline restores risk-stratified LDL-C goals, replaces the Pooled Cohort Equations with PREVENT-ASCVD, recommends measuring Lp(a) at least once, and formalizes ApoB and coronary calcium scoring

  38. Guideline Updates G12: Hypertension in 2025: A Universal Target, PREVENT Risk, and Race-Neutral First-Line Therapy

    The 2025 AHA/ACC multisociety guideline moves to a universal under 130/80 target, swaps the Pooled Cohort Equations for the PREVENT calculator, removes race from drug selection, and widens primary aldosteronism screening

  39. Guideline Updates G11: ACS Treatment Guidelines: What Hospitalists Need to Change in 2025

    The 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline unifies STEMI and NSTE-ACS: high-sensitivity troponin pathways, radial access, complete revascularization, tailored antithrombotics, and an aggressive discharge bundle

  40. Guideline Updates G10: Pneumonia with Drug-Resistant Pathogens: MRSA, Pseudomonas, and the Art of Not Over-Covering

    IDSA/ATS 2016 HAP/VAP guidelines, 2019 CAP risk-factor framework, and the MRSA nasal PCR that could change your next order

  41. Guideline Updates G9: GI Bleeding: Two Guidelines, Two Ends of the GI Tract, One Set of Principles That Save Lives

    ACG 2021 upper GI and 2023 lower GI guidelines — risk stratification, transfusion thresholds, endoscopy timing, and when to stop anticoagulants

  42. Guideline Updates G8: Pulmonary Embolism Just Got Its First Major Guideline — and It Introduces a New Risk Category System

    The 2026 AHA/ACC PE guideline: five clinical categories, PERT escalation, outpatient PE, and CTEPH screening

  43. Guideline Updates G7: DKA and HHS: The 2024 Consensus Report Rewrites the Textbook

    Beta-hydroxybutyrate at the bedside, subcutaneous insulin for mild DKA, and HHS resolution criteria for the first time ever

  44. Guideline Updates G6: Acute Kidney Injury: Managing What We Know While the Guidelines Catch Up

    KDIGO 2012 is still the official standard — a major update is in public review. How to practice confidently in the gap.

  45. Guideline Updates G5: COPD in 2026: Diagnosis, Groups, Exacerbations, and What to Do Before Discharge

    A deeper GOLD-based review from spirometry and ABE grouping to inpatient exacerbation management, steroid duration, NIV, eosinophils, biologics, and discharge prevention.

  46. Guideline Updates G4: Community-Acquired Pneumonia: Two Guidelines Walk Into a Hospital

    ATS 2025 update changes steroids and antibiotic duration — how to use both the 2019 and 2025 guidance together

  47. Guideline Updates G3: Sepsis and Septic Shock: What the 2026 Guidelines Change

    The Surviving Sepsis Campaign returns — 46 new statements, and the 1-hour clock just got more nuanced

  48. Guideline Updates G2: Atrial Fibrillation Guideline Update

    2023 ACC/AHA/ACCP/HRS Guideline for Diagnosis and Management of Atrial Fibrillation, with 2024 ESC AF-CARE context

  49. Guideline Updates G1: Heart Failure Guideline Update

    2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure, with 2023 ESC focused update context

Type above to search every episode's transcript for a word or phrase. Matches are scoped to this podcast.

Searching…

We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.

No matches for "" in this podcast's transcripts.

Showing of matches

No topics indexed yet for this podcast.

Loading reviews...

ABOUT THIS SHOW

AZense Guideline Updates is the companion podcast to AZense Journal Club. Each episode distills a major clinical practice guideline into a practical bedside reference for residents, hospitalists, PAs, NPs, and practicing clinicians. AI-generated voices, physician-reviewed scripts from Azense Medical Education, an Azense AI LLC educational project. For clinical education only, not individual medical advice.

HOSTED BY

Azense Medical Education

Produced by Azense AI LLC

Frequently Asked Questions

How many episodes does AZense Guideline Updates have?

AZense Guideline Updates currently has 49 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.

What is AZense Guideline Updates about?

AZense Guideline Updates is the companion podcast to AZense Journal Club. Each episode distills a major clinical practice guideline into a practical bedside reference for residents, hospitalists, PAs, NPs, and practicing clinicians. AI-generated voices, physician-reviewed scripts from Azense...

How often does AZense Guideline Updates release new episodes?

AZense Guideline Updates has 49 episodes. Check the episode list to see recent publication dates and frequency.

Where can I listen to AZense Guideline Updates?

You can listen to AZense Guideline Updates on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.

Who hosts AZense Guideline Updates?

AZense Guideline Updates is created and hosted by Azense Medical Education.
URL copied to clipboard!